Cite
HARVARD Citation
Lassman, A. et al. (n.d.). Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627). Neuro-oncology. 17 (7), pp. 992-998. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lassman, A. et al. (n.d.). Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627). Neuro-oncology. 17 (7), pp. 992-998. [Online].